Reprogramming the microenvironment with tumor-selective angiotensin blockers enhances cancer immunotherapy.
Chauhan VP, Chen IX, Tong R, Ng MR, Martin JD, Naxerova K, Wu MW, Huang P, Boucher Y, Kohane DS, Langer R, Jain RK.
Chauhan VP, et al. Among authors: langer r.
Proc Natl Acad Sci U S A. 2019 May 28;116(22):10674-10680. doi: 10.1073/pnas.1819889116. Epub 2019 Apr 30.
Proc Natl Acad Sci U S A. 2019.
PMID: 31040208
Free PMC article.